MedTrace Logo

UltraMTP in Adult Trauma Patients Undergoing Surgery Within 24 Hours: Effects on Mortality and Clinical Outcomes

NCT04866953 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2024-03-05

No results posted yet for this study

Summary

The purpose of this study is to determine the effects of ultraMTP (\>/=30 units pRBC within 24 hours) in trauma patients on mortality and secondary outcomes. The aim is to determine if there is a set number of pRBC units transfused in adult trauma patients undergoing surgery within 24 hours, after which mortality is inevitable and further transfusions are futile.

Conditions

  • Trauma
  • Blood Transfusion Complication
  • Death

Interventions

OTHER

Blood transfusion

Number of units of blood received within 24 hours of admission

Sponsors & Collaborators

  • University of California, Irvine

    collaborator OTHER

  • University of California, Davis

    collaborator OTHER

  • University of Texas

    collaborator OTHER

  • University of Miami

    collaborator OTHER

  • University of Chicago

    collaborator OTHER

  • Medical College of Wisconsin

    collaborator OTHER

  • Tulane University School of Medicine

    collaborator OTHER

  • University of Arkansas

    collaborator OTHER

  • University of Southern California

    lead OTHER

Principal Investigators

  • Catherine M Kuza, MD · University of Southern California

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-15
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04866953 on ClinicalTrials.gov